Navigation Links
FDA Will Wait for Trial Results on Vytorin
Date:1/25/2008

Early findings saw no medical benefit; heart expert calls it 'second-line' medication

FRIDAY, Jan. 25 (HealthDay News) -- The controversy surrounding the highly promoted cholesterol-lowering drug Vytorin continued Friday when U.S. health officials said they would review the medication's effectiveness, but only after final trial results were completed.

The debate began earlier this month when preliminary results of the so-called Enhance trial showed that Vytorin -- a combination of two cholesterol drugs -- had little medical benefit.

"We have not yet received a final study report and can't explain why Vytorin didn't lead to lesser amounts of plaque compared to patients treated with simvastatin alone," Dr. John Jenkins, director of the FDA's Office of New Drugs, Center for Drug Evaluation and Research, said during an afternoon teleconference.

A study released Jan. 14 by the makers of Vytorin found that the drug -- a combination of the Zocor (simvastatin) and Zetia (ezetimibe) -- may be no more effective at reducing the build-up of plaque in the arteries than Zocor alone. About 60 percent of U.S. patients who are taking Zetia now receive the drug as part of Vytorin.

The FDA expects to receive the final report on Vytorin in the next several months, Jenkins said.

"Once we receive the final study report, we estimate it will take as long as six months for us to fully evaluate the results of the Enhance study," he said. "And we will be considering whether any further action is warranted in regard to Zetia or Vytorin, and also whether this study has any impact on our approach to the approval of lipid-lowering drugs."

The Enhance trial found that although cholesterol was lowered, the pace at which artery-clogging plaques formed within vessels almost doubled in patients taking Vytorin, compared to those taking Zocor alone.

The FDA noted the trial was not designed to detect any differen
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Anti-Clotting Drug Trial Shortened by Bleeding Problems
2. Malaria Vaccine Shows Promise in Small Trial
3. Debate over safety of gene therapy trials focuses on issue of informed consent
4. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
6. Black Americans Still Wary of Clinical Trials
7. Vaccines for Ovarian and Breast Cancer in Early Trials
8. Industrial Solvent May Increase Risk for Parkinsonism
9. Industrial Solvent May Increase Risk for Parkinsons Disease
10. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
11. New study: US ranks last among other industrialized nations on preventable deaths
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Will Wait for Trial Results on Vytorin
(Date:8/29/2014)... York, New York (PRWEB) August 29, 2014 ... from cardiac arrest following a series of dialysis treatments ... that alleges her death was the result of Fresenius ... LLP reports. The family’s lawsuit, which was file d ... claims that the use of the products resulted in ...
(Date:8/29/2014)... AURORA, Colo. (Sept. 2, 2014) A team of ... has reported the breakthrough discovery of a process to ... patients. These findings could have implications that extend beyond ... and autoimmune diseases., In an article published ... the Charles C. Gates Center for Regenerative Medicine and ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... poised to begin accepting applications next month for ... are transitioning into accepting marijuana as a legalized ... and dispensaries will be permitted to operate in ... communities will be best suited to handle legal ...
(Date:8/29/2014)... LiveOps, Inc., the global leader in ... that LiveOps has been selected as a call center ... Strength Telethon for the third year in a row. ... to support MDA’s mission to help children and adults ... muscle disease. This year’s program includes performances by Bret ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Thirteen ... the prestigious Great 100 Nurses in North ... recognizes nursing excellence and provides scholarships to nursing students ... recognized from Novant Health Presbyterian Medical Center ... Lisa Kelley, Nora King, Lissa Ready, Amber Segerlin, Carmen ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Great 100 Honors 13 Novant Health Nurses 2
... Feb. 3 President Obama,s budget proposals to reduce ... harm fundraising for nonprofit hospitals by thwarting giving by wealthy ... and underinsured, according to the Association for Healthcare Philanthropy whose ... systems across the U.S. and Canada . , "Despite ...
... MATEO, Calif. , Feb. 3 SCAN Health Plan ... Northern California exceeded company projections with more than 3,100 ... Eligible individuals may continue to join SCAN until March 31 ... California and Arizona , SCAN is now available to ...
... inflammatory chemokine were significantly elevated in patients with ... research conducted by scientists at the Jefferson Pancreatic, ... data at the 5th Annual Academic Surgical Congress, ... that obesity is correlated with inflammation. Similarly, studies ...
... European Association for Predictive, Preventive and Personalised Medicine have ... Journal . Creating a reliable scientific platform for ... in biomedicine and laboratory medicine, the EPMA Journal ... of predictive, preventive and personalised medicine. The ...
... , ... Conn. , Feb. 3 The National Organization for Rare ... DETECTIVES , will serve as media and program partners for Rare Disease ... U.S. observance of Rare Disease Day, an event designed to call attention ...
... - People have typically viewed the benefits that accrue with ... A new paper in the February 1st issue of ... internal rewards as well. Dr. Martinez and colleagues found ... the density of dopamine D2/D3 receptors in the striatum, a ...
Cached Medicine News:Health News:Obama's Budget Proposals Will Thwart Charitable Giving to Keep Nonprofit Hospitals Operating, Association for Healthcare Philanthropy Says 2Health News:Obama's Budget Proposals Will Thwart Charitable Giving to Keep Nonprofit Hospitals Operating, Association for Healthcare Philanthropy Says 3Health News:SCAN Health Plan's Northern California Launch Embraced by Local Seniors 2Health News:Springer publishes new journal in predictive, preventive and personalized medicine 2Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 2Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 3Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 4Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 5Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 6Health News:Brain dopamine receptor density correlates with social status 2
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Services Industry (U.S.): Analytics, Extensive Financial ... 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance Services ...
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com announces ... in its catalogue: North America Laparoscopes ... http://www.reportlinker.com/p02343464/North-America-Laparoscopes-Market-Outlook-to-2020.html North America Laparoscopes Market ... report, "North America Laparoscopes Market Outlook to 2020", ... Laparoscopes market. The report provides value, in millions ...
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Reimbursement Landscape Poland " an essential source of ... healthcare market and provides insights into the demographic, ... the report provides valuable insights into the trends ...
Breaking Medicine Technology:Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5
... of the leading supporters of the Rocks Against Cancer ... for the Arts in New York City. Proceeds from the event ... (SU2C), an initiative created to speed the development and deployment ... celebrity chairperson of Rocks Against Cancer is actor John Lithgow. ...
... N.Y., Sept. 8 Misonix, Inc. (Nasdaq: ... ultrasonic medical device technology, which worldwide is used for ... year, exclusive distribution agreement with Cormedica s.a.s.  Based near ... Cutter. The agreement provides Cormedica with the rights to ...
Cached Medicine Technology:Elekta Among Major Sponsors of Rocks Against Cancer Fundraiser 2Elekta Among Major Sponsors of Rocks Against Cancer Fundraiser 3Misonix Announces New Distribution Agreement for France 2Misonix Announces New Distribution Agreement for France 3
... Activa Parkinson's Control Therapy uses electrical ... some of the most disabling motor ... Control Therapy is a safe and ... Parkinson's patients. Activa Therapy controls rigidity, ...
... It features over 600 TV lines of ... has four color temperature selections, scanning size selection ... control allows the user to easily set up ... settings for brightness, chroma, phase, contrast, volume and ...
Craniosorb Absorbable Fixation System (AFS) is uniquely designed to offer simple and reproducible fixation of the cranial flap and allow for complete absorption of the plating system over time....
PoleStar N-10 is a compact MRI unit that does not require a specially constructed surgery suite. The magnetic field is confined to the volume between the magnet poles and it's immediate neighborhood....
Medicine Products: